ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30798-25mg |
|
913088-80-9 |
Cenobamate (YKP3089)
|
0 | C10H10ClN5O2 | |
GC30798-10mg |
|
913088-80-9 |
Cenobamate (YKP3089)
|
0 | C10H10ClN5O2 | |
GC30798-5mg |
|
913088-80-9 |
Cenobamate (YKP3089)
|
0 | C10H10ClN5O2 | |
GC30798-10mM(1mLinDMSO) |
|
913088-80-9 |
Cenobamate (YKP3089)
|
0 | C10H10ClN5O2 | |
GC30797-100mg |
|
1187020-80-9 |
lumateperone Tosylate (ITI-007)
|
0 | C31H36FN3O4S | |
GC30797-50mg |
|
1187020-80-9 |
lumateperone Tosylate (ITI-007)
|
0 | C31H36FN3O4S | |
GC30797-10mg |
|
1187020-80-9 |
lumateperone Tosylate (ITI-007)
|
0 | C31H36FN3O4S | |
GC30797-5mg |
|
1187020-80-9 |
lumateperone Tosylate (ITI-007)
|
0 | C31H36FN3O4S | |
GC30797-10mM(1mLinDMSO) |
|
1187020-80-9 |
lumateperone Tosylate (ITI-007)
|
0 | C31H36FN3O4S | |
GC30796-100mg |
|
839713-36-9 |
Nelotanserin (APD125)
|
0 | C18H15BrF2N4O2 | |
GC30796-50mg |
|
839713-36-9 |
Nelotanserin (APD125)
|
0 | C18H15BrF2N4O2 | |
GC30796-10mg |
|
839713-36-9 |
Nelotanserin (APD125)
|
0 | C18H15BrF2N4O2 | |
GC30796-5mg |
|
839713-36-9 |
Nelotanserin (APD125)
|
0 | C18H15BrF2N4O2 | |
GC30796-1mg |
|
839713-36-9 |
Nelotanserin (APD125)
|
0 | C18H15BrF2N4O2 | |
GC30796-10mM(1mLinDMSO) |
|
839713-36-9 |
Nelotanserin (APD125)
|
0 | C18H15BrF2N4O2 | |
GC30795-5g |
|
59-23-4 |
D-Galactose (D-(+)-Galactose)
|
0 | C6H12O6 | |
GC30795-500mg |
|
59-23-4 |
D-Galactose (D-(+)-Galactose)
|
0 | C6H12O6 | |
GC30795-10mM(1mLinWater) |
|
59-23-4 |
D-Galactose (D-(+)-Galactose)
|
0 | C6H12O6 | |
GC30794-100mg |
|
942123-43-5 |
Inarigivir soproxil (SB9200)
|
0 | C25H34N7O13PS | |
GC30794-50mg |
|
942123-43-5 |
Inarigivir soproxil (SB9200)
|
0 | C25H34N7O13PS | |